Dallas-based Tenet Healthcare is doubling down on its ASC growth strategy, continuing to “prioritize capital investments” in its ASC arm, United Surgical Partners International, through a robust mergers and acquisitions pipeline, executives said during an earnings call transcribed by Seeking Alpha.
Here are five more things to know
1. Tenet CEO and Chair Saum Sutaria, MD, said the company has invested nearly $300 million in ASC M&A year-to-date and expects additional acquisitions in the fourth quarter.
2. In the third quarter alone, USPI added 11 centers through acquisition and launched two de novo facilities, underscoring its active expansion strategy.
3. Dr. Sutaria noted that Tenet’s robust cash flow continues to support higher-than-expected deal activity. Historically, USPI has outspent its M&A guidance when attractive opportunities arise, reflecting its ability to act quickly on compelling assets.
4. Tenet plans to raise its 2025 capital expenditures to $875 million to $975 million, about $150 million higher at the midpoint compared to previous guidance.
5. Physicians are increasingly drawn to USPI for its ability to scale centers and transition them from single- to multi-specialty operations, helping physician partners achieve what Dr. Sutaria described as “the next level of maturity.”
